Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial

Cardiovasc Res. 2025 Jan 22:cvae266. doi: 10.1093/cvr/cvae266. Online ahead of print.

Authors

Giulio Stefanini^{1

2}, Carmelo Carlo-Stella^{1

2}, Francesco Cannata^{1

2}, Mauro Chiarito^{1

2}, Stefano Figliozzi^{1

2}, Laura Novelli^{1

2}, Costanza Lisi^{1

2}, Sara Bombace^{1

2}, Federica Catapano^{1

2}, Eleonora Indolfi^{1

2}, Cristina Panico^{1

2}, Francesco Corrado^{1

2}, Giovanna Masci^{1

2}, Rita Mazza^{1

2}, Francesca Ricci^{1

2}, Lorenzo Monti^{1

2}, Giuseppe Ferrante^{1

2}, Bernhard Reimers^{1

2}, Armando Santoro^{1

2}, Marco Francone^{1

2}, Bruno R da Costa³, Peter Jüni³, Gianluigi Condorelli^{1

2}

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele-Milan, Italy.
² IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano-Milan, Italy.
³ Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.

PMID: 39842858
DOI: 10.1093/cvr/cvae266

No abstract available